• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌树状大分子对抗急性早幼粒细胞白血病:对 HL-60 细胞的研究。

Ruthenium dendrimers against acute promyelocytic leukemia:  studies on HL-60 cells.

机构信息

Laboratory of Microscopic Imaging & Specialized Biological Techniques, Faculty of Biology & Environmental Protection, University of Lodz, Banacha12/16, Lodz 90-237, Poland.

Department of General Biophysics, Faculty of Biology & Environmental Protection, University of Lodz, Pomorska 141/143, Lodz 90-236, Poland.

出版信息

Future Med Chem. 2019 Jul;11(14):1741-1756. doi: 10.4155/fmc-2018-0274. Epub 2019 Jul 9.

DOI:10.4155/fmc-2018-0274
PMID:31287722
Abstract

Coordination of ruthenium arene fragments on carbosilane dendrimers' surface greatly increases their antitumor properties. Newly synthetized ruthenium dendrimers are water-soluble, monodisperse and stable. Since carbosilane dendrimers are good carriers of drugs and genes, the presence of ruthenium in their structure makes them promising candidates for new drug delivery systems with improved antitumor potential. Carbosilane ruthenium dendrimers are more toxic to cancer cells than normal cells. Results of several studies applied here indicate that carbosilane ruthenium dendrimers induce apoptosis in promyelocytic leukemia HL-60 cells.

摘要

芳基金属钌片段在碳硅烷树枝状大分子表面的配位极大地提高了它们的抗肿瘤特性。新合成的钌树枝状大分子具有水溶性、单分散性和稳定性。由于碳硅烷树枝状大分子是药物和基因的良好载体,其结构中存在钌使它们成为具有改进的抗肿瘤潜力的新型药物输送系统的有前途的候选物。碳硅烷钌树枝状大分子对癌细胞比对正常细胞更具毒性。这里应用的几项研究的结果表明,碳硅烷钌树枝状大分子诱导早幼粒细胞白血病 HL-60 细胞凋亡。

相似文献

1
Ruthenium dendrimers against acute promyelocytic leukemia:  studies on HL-60 cells.钌树状大分子对抗急性早幼粒细胞白血病:对 HL-60 细胞的研究。
Future Med Chem. 2019 Jul;11(14):1741-1756. doi: 10.4155/fmc-2018-0274. Epub 2019 Jul 9.
2
Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.茂基金属碳硅烷树状大分子作为一种有前途的治疗晚期前列腺癌的方法。
Eur J Med Chem. 2020 Aug 1;199:112414. doi: 10.1016/j.ejmech.2020.112414. Epub 2020 May 8.
3
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.钌树状大分子抗人急性淋巴细胞白血病 1301 细胞。
Int J Mol Sci. 2020 Jun 9;21(11):4119. doi: 10.3390/ijms21114119.
4
Ruthenium dendrimers as carriers for anticancer siRNA.钌树状大分子作为抗癌 siRNA 的载体。
J Inorg Biochem. 2018 Apr;181:18-27. doi: 10.1016/j.jinorgbio.2018.01.001. Epub 2018 Jan 12.
5
Enhancement of cytotoxicity by combining pyrenyl-dendrimers and arene ruthenium metallacages.通过将芘基树状大分子与芳烃钌金属笼结合来增强细胞毒性。
Inorg Chem. 2012 Jul 2;51(13):7119-24. doi: 10.1021/ic202739d. Epub 2012 Jun 20.
6
Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.荧光素标记的钌树状大分子的合成与表征及其作为潜在抗癌药物的研究。
Biomolecules. 2019 Aug 25;9(9):411. doi: 10.3390/biom9090411.
7
Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes.基于芳基钌(II)配合物的碳硅烷金属树状大分子的合成及抗癌活性。
Dalton Trans. 2016 Apr 28;45(16):7049-66. doi: 10.1039/c6dt00465b.
8
Design of Ru-arene Complexes for Antitumor Drugs.用于抗肿瘤药物的钌-芳烃配合物的设计
Mini Rev Med Chem. 2018;18(2):184-193. doi: 10.2174/1389557517666170510113453.
9
Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA.基于钌(II)氮杂环卡宾的有机金属树枝状大分子及其作为抗癌小分子干扰RNA递送系统的意义。
J Inorg Biochem. 2021 Oct;223:111540. doi: 10.1016/j.jinorgbio.2021.111540. Epub 2021 Jul 9.
10
Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway.双核有机钌配合物通过 DNA 损伤和活性氧介导的内质网应激途径发挥抗增殖活性。
Inorg Chem. 2019 Feb 4;58(3):2208-2217. doi: 10.1021/acs.inorgchem.8b03447. Epub 2019 Jan 24.

引用本文的文献

1
Monitoring Apoptosis and Myeloid Differentiation of Acridine Orange-Mediated Sonodynamic Therapy-Induced Human Promyelocytic Leukemia HL60 Cells.监测吖啶橙介导的声动力疗法诱导的人早幼粒细胞白血病HL60细胞的凋亡和髓系分化
J Ultrasound Med. 2025 Jan;44(1):15-34. doi: 10.1002/jum.16575. Epub 2024 Sep 10.
2
Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models.铜金属树状大分子与传统抗肿瘤药物联合用于体外模型中的癌症治疗。
Int J Mol Sci. 2023 Feb 17;24(4):4076. doi: 10.3390/ijms24044076.
3
Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.
树枝状大分子在医学应用中的安全挑战与应用策略
Pharmaceutics. 2022 Jun 17;14(6):1292. doi: 10.3390/pharmaceutics14061292.
4
Disturbance of cellular homeostasis as a molecular risk evaluation of human endothelial cells exposed to nanoparticles.细胞内稳态紊乱作为纳米颗粒暴露下人内皮细胞的分子风险评估。
Sci Rep. 2021 Feb 15;11(1):3849. doi: 10.1038/s41598-021-83291-0.
5
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.钌树状大分子抗人急性淋巴细胞白血病 1301 细胞。
Int J Mol Sci. 2020 Jun 9;21(11):4119. doi: 10.3390/ijms21114119.
6
Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.荧光素标记的钌树状大分子的合成与表征及其作为潜在抗癌药物的研究。
Biomolecules. 2019 Aug 25;9(9):411. doi: 10.3390/biom9090411.